Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea
· Delayed Price · Currency is KRW
9,040.00
-110.00 (-1.20%)
Apr 29, 2026, 3:30 PM KST
Oncocross Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 110,251 | 115,231 | 75,179 | - | - | - | |
| Market Cap Growth | -14.19% | 53.27% | - | - | - | - | |
| Enterprise Value | 92,179 | 93,538 | 62,376 | - | - | - | |
| Last Close Price | 9040.00 | 9580.00 | 6340.00 | - | - | - | |
| PS Ratio | 297.61 | 311.05 | 70.12 | - | - | - | |
| PB Ratio | 8.24 | 8.62 | 3.68 | - | - | - | |
| P/TBV Ratio | 8.27 | 8.65 | 3.68 | - | - | - | |
| EV/Sales Ratio | 248.82 | 252.49 | 58.18 | - | - | - | |
| Debt / Equity Ratio | 0.40 | 0.40 | 0.03 | 0.01 | 0.05 | 0.20 | |
| Net Debt / Equity Ratio | -1.35 | -1.35 | -0.99 | -1.00 | -1.00 | -1.08 | |
| Net Debt / EBITDA Ratio | 2.25 | 2.25 | 3.08 | 2.59 | 0.70 | 1.70 | |
| Net Debt / FCF Ratio | 1.69 | 1.69 | 3.55 | 3.36 | 0.79 | 1.84 | |
| Asset Turnover | 0.01 | 0.01 | 0.05 | 0.01 | 0.01 | 0.01 | |
| Quick Ratio | 4.11 | 4.11 | 11.35 | 15.16 | 4.47 | 7.87 | |
| Current Ratio | 4.21 | 4.21 | 11.42 | 15.25 | 4.59 | 7.93 | |
| Return on Equity (ROE) | -52.79% | -52.79% | -35.10% | -36.33% | -114.08% | - | |
| Return on Assets (ROA) | -21.43% | -21.43% | -21.69% | -32.76% | -53.18% | -27.13% | |
| Return on Capital Employed (ROCE) | -38.00% | -38.00% | -33.60% | -41.30% | -146.40% | -55.20% | |
| Earnings Yield | -8.10% | -7.75% | -8.62% | - | - | - | |
| FCF Yield | -9.71% | -9.29% | -7.56% | - | - | - | |
| Buyback Yield / Dilution | -14.12% | -14.12% | -17.54% | -1.44% | -63.74% | -0.83% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.